Given the potential for acute illness to influence p-tau-217 levels, our results raise important considerations regarding the interpretation of p-tau-217 as a diagnostic marker for Alzheimer's disease in patients with active infection. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.